Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

被引：0
|
作者：
Meghan E. Jones
Jeffrey S. Andrews
Douglas E. Faries
John Landry
Jenny Xu
Holland C. Detke
Rashna Chhabra-Khanna
David P. McDonnell
机构：
[1] Eli Lilly and Company,
[2] Eli Lilly Canada,undefined
[3] Inc.,undefined
[4] MacroStat (China) Clinical Research Co.,undefined
[5] Ltd.,undefined
[6] Lilly UK,undefined
[7] Eli Lilly and Company,undefined
来源：
BMC Psychiatry | / 15卷
关键词：
Olanzapine; Long-acting injection; Schizophrenia; Antipsychotics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Cost-Effectiveness of Olanzapine Long-Acting Injection in the Treatment of Non-Adherent Patients with Schizophrenia in the United States
    Ascher-Svanum, H.
    Furiak, N. M.
    Klein, R. W.
    Montgomery, W.
    Smolen, L. J.
    Lawson, A. H.
    Conley, R. R.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 : S4 - S4
  • [22] Interim results from a prospective, non-interventional study on the use of rVIII-SingleChain in patients with haemophilia A
    Oldenburg, J.
    Juranek, S.
    Katsarou, O.
    El Fegoun, S. Benchikh
    Pabinger, I.
    HAEMOPHILIA, 2024, 30 : 50 - 51
  • [23] Interim analysis results from the prospective, non-interventional study of ruxolitinib in patients with polycythemia vera (PAVE): safety results were consistent with previous findings
    Griesshammer, M.
    Kaempfe, D.
    Weide, R.
    Reichert, D.
    Sauer, A.
    Doerfel, S.
    Koenigsmann, M.
    Stauch, M.
    Grosser, S.
    Zander, I.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 243 - 244
  • [24] A Multicenter, Prospective, Observational, Non-interventional Cohort Study in Chinese Subjects with HBeAg Negative Chronic Hepatitis B Receiving Therapy with Peginterferon alfa: An Interim Analysis
    Chen, Xinyue
    Mao, Qianguo
    Li, Hui
    Li, Xu
    Xu, Yuqin
    Xie, Yao
    Liu, Yingxia
    Zhu, Weiping
    Dou, Xiaoguang
    Zhu, Fusheng
    Zheng, Huanwei
    Zhang, Shuqin
    Zhang, Mingxiang
    Yang, Yongfeng
    Hu, Yaoren
    Zhu, Chuanwu
    Ding, Jiguang
    Tan, Youwen
    Xie, Qing
    Sheng, Jifang
    Gao, Zhiliang
    Xie, Yi
    Ren, Hong
    Jia, Jidong
    HEPATOLOGY, 2015, 62 : 1207A - 1207A
  • [25] Safety of riociguat for chronic thromboembolic pulmonary hypertension (CTEPH): Interim data from a prospective non-interventional study in Japan
    Tanabe, Nobuhiro
    Ogo, Takeshi
    Hatano, Masaru
    Tazaki, Yoichi
    Sunaya, Toshiyuki
    Saikawa, Akira
    Sakaguchi, Toshiaki
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [26] Benefits of immunoglobulin substitution in primary and secondary immunodeficiencies: Interim analysis of a prospective, long-term non-interventional study
    Bauhofer, Artur
    Schimo, Sonja
    Klausmann, Martine
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2021, 59 (06) : 417 - 427
  • [27] Research article Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases
    Detke, Holland C.
    McDonnell, David P.
    Brunner, Elizabeth
    Zhao, Fangyi
    Sorsaburu, Sebastian
    Stefaniak, Victoria J.
    Corya, Sara A.
    BMC PSYCHIATRY, 2010, 10
  • [28] A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation
    Anand, Ernie
    Berggren, Lovisa
    Deix, Claudia
    Toth, Agoston
    McDonnell, David P.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 1349 - 1357
  • [29] Multi-center, prospective, non-interventional, observational study on the efficacy and safety of Mirabek® in adult patients with overactive bladder
    Park, Jee Soo
    Jang, Won Sik
    Kim, Jongchan
    Park, Moon-Hwa
    Ham, Won Sik
    INVESTIGATIVE AND CLINICAL UROLOGY, 2025, 66 (01) : 27 - 35
  • [30] Remission in patients with first-episode schizophrenia receiving assured antipsychotic medication: a study with risperidone long-acting injection
    Emsley, Robin
    Oosthuizen, Petrus
    Koen, Liezl
    Niehaus, Dana J. H.
    Medori, Rossella
    Rabinowitz, Jonathan
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (06) : 325 - 331
12345